LINC00313 functions as an oncogenic propellant and immunosuppressive marker in lung adenocarcinoma
Background Despite advances in treatments, the prognosis for lung adenocarcinoma (LUAD) remains poor, underscoring the urgent need to identify novel therapeutic strategies. This study was conducted to investigate the potential role of LINC00313 as a biomarker and therapeutic target for LUAD.Methods...
Saved in:
| Main Authors: | Wen Wang, Yanhui Cui, Jianfu Heng, Jingjing Li, Guoli Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Future Science OA |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/20565623.2025.2547557 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comprehensive analysis of the LINC01122/TPD52 axis as a predictive biomarker in prostate adenocarcinoma
by: Zhi Shang, et al.
Published: (2025-05-01) -
The Role of the TIMP1/LINC01615 Axis as a Regulator of the EMT Pathway in Gastric Cancer
by: Jiying Liu, et al.
Published: (2025-08-01) -
Pyroptosis-related lncRNAs are potential biomarkers for predicting prognoses and immune landscapes in patients with gastric adenocarcinoma
by: Haidu Hong, et al.
Published: (2024-11-01) -
Hypoxia-inducible APCDD1L-AS1 promotes osimertinib resistance by stabilising DLST to drive tricarboxylic acid cycle in lung adenocarcinoma
by: Quanli Zhang, et al.
Published: (2025-07-01) -
Analysis of enhancer RNA LINC00910 expression correlating with the immunoregulator STAT3 in glioblastoma cells
by: E. M. Stasevich, et al.
Published: (2024-07-01)